Trending Tickers: Revance Therapeutics, Inc. (NASDAQ:RVNC), Nature’s Sunshine Products Inc. (NASDAQ:NATR), ConocoPhillips (NYSE:COP), Celladon Corporation (NASDAQ:CLDN),

Revance Therapeutics Inc (NASDAQ:RVNC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, reports.

Revance Therapeutics, Inc. (NASDAQ:RVNC) belongs to Healthcare sector. Its weekly performance is -4.87%. On last trading day company shares ended up at $17.68. Revance Therapeutics, Inc. (NASDAQ:RVNC) distance from 50-day simple moving average (SMA50) is -4.89%.

On 25 February, Nature’s Sunshine Products Inc. (NASDAQ:NATR) reported its financial results for the fourth quarter and full year ended December 31, 2015.Net sales revenue of $80.0 million, decreased 7.7% compared to $86.7 million in the fourth quarter of 2014. On a local currency basis, net sales revenue decreased 3.2% compared to the fourth quarter of 2014. Net sales revenue was negatively impacted by

Nature’s Sunshine Products Inc. (NASDAQ:NATR) belongs to Healthcare sector. Its net profit margin is 2.20% and weekly performance is 11.44%. On last trading day company shares ended up at $8.38. Nature’s Sunshine Products Inc. (NASDAQ:NATR) distance from 50-day simple moving average (SMA50) is 1.37%.

ConocoPhillips (NYSE:COP) said it is lowering its dividend to 25 cents per share from 74 cents per share. The dividend is payable on March 1 to shareholders of record on Feb. 16. The company also reduced its 2016 capital expenditures outlook and operating cost guidance.

ConocoPhillips (NYSE:COP) shares fell -0.85% in last trading session and ended the day at $33.83. COP Gross Margin is 34.50% and its return on assets is -4.20%. ConocoPhillips (NYSE:COP) quarterly performance is -37.30%.

Celladon Corporation (NASDAQ:CLDN) announced it has set a date for a special meeting of its stockholders to vote on matters related to the proposed merger with Eiger BioPharmaceuticals, Inc. The special meeting will be held at 9:00 a.m., local time, on March 21, 2016 at 12255 El Camino Real, Suite 300, San Diego, California 92130.

On 29 February, Celladon Corporation (NASDAQ:CLDN) shares advanced 2.88% and was closed at $0.93. Celladon Corporation (NASDAQ:CLDN) year to date (YTD) performance is -36.73%.

Delta Air Lines, Inc. (NYSE:DAL) started offering customers refunds and fee-waived changes for travel to Zika-hit areas. Delta Air Lines customers must make Zika-related travel changes by Feb. 29

Delta Air Lines, Inc. (NYSE:DAL) ended the last trading day at $48.24. Company weekly volatility is calculated as 2.59% and price to cash ratio as 10.93. Delta Air Lines, Inc. (NYSE:DAL) showed a weekly performance of -1.19%.

Leave a Reply

Your email address will not be published. Required fields are marked *